Form D · Biotechnology
Phylex BioSciences, Inc.
Del Mar, CA · CIK 0001813525
Offering snapshot reported May 28, 2020 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 28, 2020 | Initial | $250,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-367846
Source: Form D, filed May 28, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pascal Brandys | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1155 Camino Del Mar Suite 502
Del Mar, CA, 92014
Del Mar, CA, 92014